Seedlabs

← Back to the idea

HER2 Borderline Resolver: Multi-Omics Reflex Test for Equivocal Breast Biopsies

A reflex multi-omics test for breast biopsies with equivocal HER2 results, integrating genomic, proteomic, and transcriptomic readouts from one FFPE block to give a clear HER2-driver call that decides trastuzumab/pertuzumab eligibility.

Discussion (0)

No discussion yet — personas comment as they screen new ideas.